Cancer care in lesbian, gay, bisexual, transgender and queer populations

Gibson, Alec W; Radix, Asa; Maingi, Shail; Patel, Shilpen

doi:10.2217/fon-2017-0482

Cited by 41 publications

(40 citation statements)

References 66 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although searches were systematically conducted, the goal was to be representative rather than exhaustive; thus only articles with a primary focus on SGM cancer care delivery, patient experiences, and health outcomes were included. Guidance on the topics and search terms selected was provided through analysis of other reviews of health topics in SGM populations and specifically in cancer care delivery . In July 2017, a literature search of the PubMed/Medline, PsycInfo, Cumulative Index of Nursing and Allied Health Literature (CINAHL), and Web of Sciences databases was conducted.…”

Section: Methodsmentioning

confidence: 99%

“…Guidance on the topics and search terms selected was provided through analysis of other reviews of health topics in SGM populations 13,18 and specifically in cancer care delivery. 10,19,20 In July 2017, a literature search of the PubMed/ Medline, PsycInfo, Cumulative Index of Nursing and Allied Health Literature (CINAHL), and Web of Sciences databases was conducted. The search strategy used the following concepts, which contained multiple terms: 1) sexual and gender minority and 2) cancer; and at least 1 of the 2 following concepts: 3) cancer treatment, care, or delivery; and 4) health outcome, health care experience, or health disparity (see Supporting Table 1).…”

Section: Search Strategymentioning

confidence: 99%

See 1 more Smart Citation

Care delivery, patient experiences, and health outcomes among sexual and gender minority patients with cancer and survivors: A scoping review

Kent

Wheldon

Smith

et al. 2019

Cancer

View full text Add to dashboard Cite

Sexual and gender minorities (SGMs) face a disproportionate burden of cancer, yet little is known about the experiences and specific needs of these underserved populations in cancer care delivery. The authors conducted a scoping review to characterize the literature on cancer care delivery, health outcomes, and health care experiences for patients with cancer and survivors identifying as SGM. In total, 1176 peer‐reviewed citations were identified after a systematic search of the PubMed/Medline, PsycInfo, Cumulative Index of Nursing and Allied Health Literature (CINAHL), and Web of Sciences databases without restriction on publication date. The details captured included study aims, design, population, cancer site, and main findings. Thirty‐seven studies published from 1998 to 2017 met the study criteria. Most studies were conducted in the post‐treatment survivorship phase of the continuum (n = 30), and breast cancer was the most common cancer site (n = 20). There were only 2 intervention studies. The studies reviewed were classified under the following areas of focus: 1) disclosure of sexual orientation and gender identity, 2) quality of care, 3) psychosocial impact of/ adjustment to cancer, 4) social support, 5) sexual functioning, and 6) health risks/health behavior. Very little research reported an assessment of gender minority status or included a focus on gender minorities (n = 7). This review revealed substantial research gaps given a lack of population‐based data and small sample sizes, likely related to the absence of systematic collection of sexual orientation and gender identity information in the cancer care context. Deficient research in this area likely perpetuates health disparities. Further research is needed to identify and remove the barriers to delivering high‐quality care to SGM individuals with cancer.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Search Strategymentioning

confidence: 99%

Care delivery, patient experiences, and health outcomes among sexual and gender minority patients with cancer and survivors: A scoping review

Kent

Wheldon

Smith

et al. 2019

Cancer

View full text Add to dashboard Cite

show abstract

“…Regrettably, even in recent years, much of the published research focused on oncology and lymphoma in the LGBTI community is mainly in the context of HIV or other sexually transmitted diseases. Very limited data is available regarding transgender patients, particular those with lymphoid malignancies, and the available data is often in the context of small observational studies (30,32). Data regarding the management of lymphoma in HIV negative sexual minority patients is significantly lacking and is often limited to case reports.…”

Section: Methodsmentioning

confidence: 99%

“…Influential bodies such as ASCO and the American Medical Association have recently released statements acknowledging the disparities that exist among SGM individuals (41). SGM patients often face unique psychosocial challenges during both treatment and in survivorship (32,33,42). In particular, these patients are often stigmatized and may face unique challenges with bereavement.…”

Section: Methodsmentioning

confidence: 99%

Disparities in lymphoma on the basis of race, gender, HIV status, and sexual orientation

2017

View full text Add to dashboard Cite

Lymphoid malignancies account for the sixth leading cause of death in the US, and, although survival is improving overall, this trend is not applicable to all patients. In this review, we describe disparities in the initial presentation, treatment, and outcomes across a diverse group of lymphoma patients on the basis of gender, race, HIV status, and sexual orientation. Identifying these disparities will hopefully lead to improved outcomes in these groups of lymphoma patients in the future.

show abstract

“…12,13 Although this research [14][15][16] can reveal disparities in selfreported health issues, it cannot provide data on the broader health care experience of transgender individuals, including health care utilization, diagnoses, or health outcomes, such as the effects of hormone therapy 17 or cancer survivorship. 18 Because Medicare beneficiaries are not asked about their gender identity and/or transgender status in a systematic way, there is no definitive information in administrative data that can identify transgender beneficiaries. In addition, beneficiaries can change their recorded sex in Medicare claims data as they transition; however, there is no indication in the data whether that information has been updated.…”

Section: Introductionmentioning

confidence: 99%

Identifying Medicare Beneficiaries Accessing Transgender-Related Care in the Era of ICD-10

et al. 2019

View full text Add to dashboard Cite

Purpose: The study purpose was to describe trends in the size and demographics of the population of transgender Medicare beneficiaries identified using International Classification of Diseases (ICD) Clinical Modification codes over time. We also assessed how the change from ICD, Ninth Revision (ICD-9) diagnosis codes to ICD, 10th Revision (ICD-10) diagnosis codes in October 2015 has affected the ability to identify transgender beneficiaries within claims data. Methods: We used Medicare Fee-for-Service claims within the Centers for Medicare & Medicaid Services Chronic Conditions Data Warehouse from 2010 through 2016 to identify transgender beneficiaries. We linked these data to Medicare enrollment records to study demographic trends. Results: Within the Medicare program, the number of beneficiaries identified as transgender through claims data in each year has increased from 2088 beneficiaries in 2010 to 10,242 beneficiaries in 2016 (a 390% increase). The highest numbers of transgender beneficiaries were identified in 2015 and 2016, which coincide with the change to ICD-10. Similarly, more beneficiaries were identified as transgender in the 12 months after the change to ICD-10 (N = 8733) than in the 12 months before (N = 4857). Conclusion: Given that a first and critical step to better understand and eliminate health disparities and deliver culturally competent care is to identify and characterize the population of interest, this study provides an innovative view into how the change to the ICD-10 coding system affects the ability to study a transgender cohort within Medicare claims data.

show abstract

Cancer care in lesbian, gay, bisexual, transgender and queer populations

Cited by 41 publications

References 66 publications

Care delivery, patient experiences, and health outcomes among sexual and gender minority patients with cancer and survivors: A scoping review

Care delivery, patient experiences, and health outcomes among sexual and gender minority patients with cancer and survivors: A scoping review

Disparities in lymphoma on the basis of race, gender, HIV status, and sexual orientation

Identifying Medicare Beneficiaries Accessing Transgender-Related Care in the Era of ICD-10

Contact Info

Product

Resources

About